Medulloblastoma in an Adult With Late Extraneural Metastases to the Mediastinum

por Ghose, Abhimanyu, Morris, John C., Breneman, John C., Essell, James, Wang, Jiang, Benzaquen, Sadia
Publicado 2014

A Phase II Trial Evaluating the Safety of Rapid Infusion of Ofatumumab in Patients with Previously Treated Chronic Lymphocytic Leukemia

por Donnellan, William, Berdeja, Jesus G., Shipley, Diana, Arrowsmith, Edward R., Wright, David, Lunin, Scott, Brown, Richard, Essell, James H., Flinn, Ian W.
Publicado 2017

An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma

por Burke, John M., Shustov, Andrei, Essell, James, Patel-Donnelly, Dipti, Yang, Jay, Chen, Robert, Ye, Wei, Shi, Wen, Assouline, Sarit, Sharman, Jeff
Publicado 2018

ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease

por Jagasia, Madan, Lazaryan, Aleksandr, Bachier, Carlos R., Salhotra, Amandeep, Weisdorf, Daniel J., Zoghi, Behyar, Essell, James, Green, Laurie, Schueller, Olivier, Patel, Jeegar, Zanin-Zhorov, Alexandra, Weiss, Jonathan M., Yang, Zhongming, Eiznhamer, David, Aggarwal, Sanjay K., Blazar, Bruce R., Lee, Stephanie J.
Publicado 2021

Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignancies

por Davids, Matthew S., O’Connor, Owen A., Jurczak, Wojciech, Samaniego, Felipe, Fenske, Timothy S., Zinzani, Pier Luigi, Patel, Manish R., Ghosh, Nilanjan, Cheson, Bruce D., Derenzini, Enrico, Brander, Danielle M., Reeves, James A., Knopińska-Posłuszny, Wanda, Allan, John N., Phillips, Tycel, Caimi, Paolo F., Lech-Maranda, Ewa, Burke, John M., Agajanian, Richy, Pettengell, Ruth, Leslie, Lori A., Cheah, Chan Y., Fonseca, Gustavo, Essell, James, Chavez, Julio C., Pagel, John M., Sharman, Jeff P., Hsu, Yanzhi, Miskin, Hari P., Sportelli, Peter, Weiss, Michael S., Flinn, Ian W.
Publicado 2021